Top Markets
Coin of the day
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd

HLB Pharmaceutical Co., Ltd

047920
Classificação em ações #19377
HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to... HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to the research and development of peptide-based drugs. Its product line encompasses a wide array of pharmaceutical preparations. These include medications for skeletal muscle relaxation, tranquilizing effects, antihistamine action, hypertension management, pain alleviation, anti-itching, astringent properties, anti-inflammatory relief, alimentary system support, metabolic regulation, ophthalmic conditions, local anesthesia, anti-arteriosclerosis, expectoration, fever reduction, analgesia, diabetes control, chemotherapy, peptic ulcer treatment, central nervous system issues, bacterial infections (antibiotics), digestive assistance, antacid needs, dental care, multivitamin supplementation, parasitic skin diseases, dermatological concerns, urogenital organ function, amino acid replacement, cough suppression, mucus thinning, parasitic worm elimination, diarrhea relief, circulatory system disorders, vitamin deficiencies, skin softening, hemorrhoid treatment, and liver ailments. Additionally, the company is actively developing CTT-004, an investigational therapy for ataxia associated with spinocerebellar degeneration, and offers Contract Manufacturing Organization (CMO) services. The enterprise, established in 1998, was formerly recognized as Mediforum Pharmaceutical Incorporation before adopting the name HLB Pharmaceutical Co., Ltd in October 2020. Its headquarters are located in Namyangju-Si, South Korea.
Preço da ação
$5.01
Valor de mercado
$164.43M
Variação (1 dia)
-4.98%
Variação (1 ano)
-48.54%
País
KR
Negociar HLB Pharmaceutical Co., Ltd (047920)

Categoria

Histórico de preços das ações de HLB Pharmaceutical Co., Ltd (047920)
Preço de fecho mais alto: $5.74 em 2026-08-01

Preço de fecho mais baixo: $5.98 em 2015-12-01
Histórico de preços das ações da HLB Pharmaceutical Co., Ltd de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -5.24%
2025 -31.57%
2024 45.66%
2023 13.74%
2022 -20.69%
2021 -24.31%
2020 249.25%
2019 15.40%
2018 -34.85%
2017 35.41%
2016 -27.22%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$165.29 31.69%
DE
$38.23 28.07%
JP
$223.18 30.81%
CH
$21.14 15.75%
IN